Ascorbate modulates antibacterial mechanisms in experimental pneumococcal pneumonia.
To evaluate the influence of vitamin C on pulmonary antibacterial mechanisms, normal CD-1 mice were administered sodium ascorbate (200 mg/kg/24 h) and challenged intratracheally with type 3 Streptococcus pneumoniae. Survival rates were similar in ascorbate-treated and control animals. When infected with a high inoculum (1 X 10(6) cfu), animals given vitamin C demonstrated a significant enhancement in their capacity to clear viable pneumococci from the lungs at 24 h after challenge; the augmented pulmonary clearance was associated with an increased influx of granulocytes at 6 and 24 h. After infection with a lower inoculum (1 X 10(5) cfu), animals treated with the vitamin exhibited a significant advantage in pulmonary clearance and granulocyte recruitment but at 6 h only. After a very low inoculum challenge (1 X 10(4) cfu), the clearance of viable pneumococci was retarded in ascorbate-treated mice. In vitro, the pneumococcidal capacity of resident alveolar macrophages from animals given vitamin C was significantly reduced, but the ability of these cells to generate leukocyte chemoattractant activity after stimulation with the calcium ionophore A23187 remained unaltered. We conclude that in the mouse, large doses of vitamin C alter pulmonary defense mechanisms against S. pneumoniae; however, these changes do not appear to convey a substantial advantage to the host.
D000818:Animals; D001205:Ascorbic Acid / Q000627:therapeutic use*; D001696:Biomechanical Phenomena; D002630:Chemotactic Factors / Q000378:metabolism; D007249:Inflammation / Q000473:pathology; D016209:Interleukin-8; D008168:Lung / Q000382:microbiology; D008264:Macrophages / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D009504:Neutrophils / Q000473:pathology; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology / Q000401:mortality; D011650:Pulmonary Alveoli / Q000473:pathology; D013296:Streptococcus pneumoniae / Q000302:isolation & purification
D002630:Chemotactic Factors; D016209:Interleukin-8; D001205:Ascorbic Acid